We are live on ! Find out more
HNWAG

High Net Worth Advisory Group Portfolio holdings

AUM $429M
1-Year Est. Return 17.69%
This Fund
S&P 500
This Quarter Est. Return
+9.76%
1 Year Est. Return
+17.69%
3 Year Est. Return
+58.24%
5 Year Est. Return
10 Year Est. Return
AUM
$286M
AUM Growth
Cap. Flow
+$279M
Cap. Flow %
97.48%
Top 10 Hldgs %
31.48%
Holding
694
New
691
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 13.01%
2 Healthcare 10.92%
3 Consumer Staples 6.17%
4 Consumer Discretionary 5.76%
5 Industrials 5.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MTB icon
601
M&T Bank
MTB
$36B
$5K ﹤0.01%
+35
New +$5.37K
MU icon
602
Micron Technology
MU
$1.02T
$5K ﹤0.01%
+50
New +$3.9K
NEM icon
603
Newmont
NEM
$98.5B
$5K ﹤0.01%
+80
New +$4.53K
NKE icon
604
Nike
NKE
$62.5B
$5K ﹤0.01%
+30
New +$4.95K
PBW icon
605
Invesco WilderHill Clean Energy ETF
PBW
$409M
$5K ﹤0.01%
+77
New +$6.3K
PLTR icon
606
Palantir
PLTR
$315B
$5K ﹤0.01%
+300
New +$6.63K
RWT
607
Redwood Trust
RWT
$619M
$5K ﹤0.01%
+400
New +$5.41K
THQ
608
abrdn Healthcare Opportunities Fund
THQ
$773M
$5K ﹤0.01%
+190
New +$4.56K
VRM icon
609
Vroom Inc
VRM
$37.5M
$5K ﹤0.01%
+6
New +$8.08K
VTRS icon
610
Viatris
VTRS
$20.5B
$5K ﹤0.01%
+343
New +$4.58K
ENLC
611
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
$5K ﹤0.01%
+770
New +$5.57K
XM
612
DELISTED
Qualtrics International Inc. Class A Common Stock
XM
$5K ﹤0.01%
+150
New +$5.83K
RUBY
613
DELISTED
Rubius Therapeutics, Inc
RUBY
$5K ﹤0.01%
+500
New +$6.93K
ADAP
614
DELISTED
Adaptimmune Therapeutics
ADAP
$4K ﹤0.01%
+1,000
New +$4.55K
BIIB icon
615
Biogen
BIIB
$29.5B
$4K ﹤0.01%
+15
New +$3.86K
CTSH icon
616
Cognizant
CTSH
$22.3B
$4K ﹤0.01%
+50
New +$4.02K
CVGW
617
DELISTED
Calavo Growers
CVGW
$4K ﹤0.01%
+100
New +$4.09K
EXAS
618
DELISTED
Exact Sciences
EXAS
$4K ﹤0.01%
+50
New +$4.41K
FL
619
DELISTED
Foot Locker
FL
$4K ﹤0.01%
+100
New +$4.75K
FSLY icon
620
Fastly Inc
FSLY
$3.14B
$4K ﹤0.01%
+100
New +$4.35K
LYEL icon
621
Lyell Immunopharma
LYEL
$318M
$4K ﹤0.01%
+25
New +$5.58K
PTY icon
622
PIMCO Corporate & Income Opportunity Fund
PTY
$2.47B
$4K ﹤0.01%
+219
New +$3.9K
TEVA icon
623
Teva Pharmaceuticals
TEVA
$36.2B
$4K ﹤0.01%
+519
New +$4.68K
UBER icon
624
Uber
UBER
$139B
$4K ﹤0.01%
+100
New +$4.31K
ADIL
625
Adial Pharmaceuticals
ADIL
$6.15M
$3K ﹤0.01%
+2
New +$3.94K

Similar funds

High Net Worth Advisory Group's Q4 2021 Portfolio in Review

Q4 2021 is the first quarter with a 13F filing on record for High Net Worth Advisory Group, which disclosed 694 positions worth $286M. Its ten largest holdings account for 31% of the portfolio.

Its largest position is Vanguard S&P 500 ETF: 37,803 shares worth $16.5M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, followed by Healthcare and Consumer Staples.

  • High Net Worth Advisory Group's largest Q4 2021 buy was Vanguard S&P 500 ETF: 37,803 shares worth $16.5M.
  • High Net Worth Advisory Group's ten largest holdings make up 31% of its $286M portfolio in Q4 2021.
  • High Net Worth Advisory Group disclosed 694 positions in Q4 2021, its first 13F filing on record.

Based on High Net Worth Advisory Group's 13F filing for Q4 2021, filed 27 Apr 2022.